These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

465 related articles for article (PubMed ID: 15298348)

  • 1. Evaluation of orally active poly(ADP-ribose) polymerase inhibitor in streptozotocin-diabetic rat model of early peripheral neuropathy.
    Li F; Szabó C; Pacher P; Southan GJ; Abatan OI; Charniauskaya T; Stevens MJ; Obrosova IG
    Diabetologia; 2004 Apr; 47(4):710-7. PubMed ID: 15298348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aldose reductase inhibition counteracts oxidative-nitrosative stress and poly(ADP-ribose) polymerase activation in tissue sites for diabetes complications.
    Obrosova IG; Pacher P; Szabó C; Zsengeller Z; Hirooka H; Stevens MJ; Yorek MA
    Diabetes; 2005 Jan; 54(1):234-42. PubMed ID: 15616034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-dose poly(ADP-ribose) polymerase inhibitor-containing combination therapies reverse early peripheral diabetic neuropathy.
    Li F; Drel VR; Szabó C; Stevens MJ; Obrosova IG
    Diabetes; 2005 May; 54(5):1514-22. PubMed ID: 15855340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nicotinamide reverses neurological and neurovascular deficits in streptozotocin diabetic rats.
    Stevens MJ; Li F; Drel VR; Abatan OI; Kim H; Burnett D; Larkin D; Obrosova IG
    J Pharmacol Exp Ther; 2007 Jan; 320(1):458-64. PubMed ID: 17021258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Poly(ADP-ribose) polymerase inhibition alleviates experimental diabetic sensory neuropathy.
    Ilnytska O; Lyzogubov VV; Stevens MJ; Drel VR; Mashtalir N; Pacher P; Yorek MA; Obrosova IG
    Diabetes; 2006 Jun; 55(6):1686-94. PubMed ID: 16731831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the effects of inhibitors of aldose reductase and sorbitol dehydrogenase on neurovascular function, nerve conduction and tissue polyol pathway metabolites in streptozotocin-diabetic rats.
    Cameron NE; Cotter MA; Basso M; Hohman TC
    Diabetologia; 1997 Mar; 40(3):271-81. PubMed ID: 9084964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New therapeutic and biomarker discovery for peripheral diabetic neuropathy: PARP inhibitor, nitrotyrosine, and tumor necrosis factor-{alpha}.
    Drel VR; Lupachyk S; Shevalye H; Vareniuk I; Xu W; Zhang J; Delamere NA; Shahidullah M; Slusher B; Obrosova IG
    Endocrinology; 2010 Jun; 151(6):2547-55. PubMed ID: 20357221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role for nitrosative stress in diabetic neuropathy: evidence from studies with a peroxynitrite decomposition catalyst.
    Obrosova IG; Mabley JG; Zsengellér Z; Charniauskaya T; Abatan OI; Groves JT; Szabó C
    FASEB J; 2005 Mar; 19(3):401-3. PubMed ID: 15611153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A protein kinase C-beta-selective inhibitor ameliorates neural dysfunction in streptozotocin-induced diabetic rats.
    Nakamura J; Kato K; Hamada Y; Nakayama M; Chaya S; Nakashima E; Naruse K; Kasuya Y; Mizubayashi R; Miwa K; Yasuda Y; Kamiya H; Ienaga K; Sakakibara F; Koh N; Hotta N
    Diabetes; 1999 Oct; 48(10):2090-5. PubMed ID: 10512378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment with Actovegin® improves sensory nerve function and pathology in streptozotocin-diabetic rats via mechanisms involving inhibition of PARP activation.
    Dieckmann A; Kriebel M; Andriambeloson E; Ziegler D; Elmlinger M
    Exp Clin Endocrinol Diabetes; 2012 Mar; 120(3):132-8. PubMed ID: 22020669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An aldose reductase inhibitor reverses early diabetes-induced changes in peripheral nerve function, metabolism, and antioxidative defense.
    Obrosova IG; Van Huysen C; Fathallah L; Cao XC; Greene DA; Stevens MJ
    FASEB J; 2002 Jan; 16(1):123-5. PubMed ID: 11709499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of poly(ADP-ribose) polymerase activation in diabetic neuropathy.
    Obrosova IG; Li F; Abatan OI; Forsell MA; Komjáti K; Pacher P; Szabó C; Stevens MJ
    Diabetes; 2004 Mar; 53(3):711-20. PubMed ID: 14988256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective effects of 4-amino1,8-napthalimide, a poly (ADP-ribose) polymerase inhibitor in experimental diabetic neuropathy.
    Sharma SS; Kumar A; Kaundal RK
    Life Sci; 2008 Mar; 82(11-12):570-6. PubMed ID: 18262571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An aldose reductase inhibitor, TAT, reduces ADP-induced platelet hyperaggregation in streptozotocin-induced diabetic rats with neuropathy.
    Hara T; Nakamura J; Koh N; Sakakibara F; Hamada Y; Sasaki H; Naruse K; Nakashima E; Takeuchi N; Inukai S
    J Lab Clin Med; 1995 Dec; 126(6):541-7. PubMed ID: 7490513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amelioration by the Ca2+ antagonist, nimodipine of an existing neuropathy in the streptozotocin-induced, diabetic rat.
    Kappelle AC; Bravenboer B; van Buren T; Traber J; Erkelens DW; Gispen WH
    Br J Pharmacol; 1993 Mar; 108(3):780-5. PubMed ID: 8467365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of abnormalities in motor nerve conduction and nerve blood-flow by a prostacyclin analog, beraprost sodium, in streptozotocin-induced diabetic rats.
    Hotta N; Koh N; Sakakibara F; Nakamura J; Hamada Y; Wakao T; Hara T; Mori K; Naruse K; Nakashima W
    Prostaglandins; 1995 Jun; 49(6):339-49. PubMed ID: 7480803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of propionyl-L-carnitine on motor nerve conduction, autonomic cardiac function, and nerve blood flow in rats with streptozotocin-induced diabetes: comparison with an aldose reductase inhibitor.
    Hotta N; Koh N; Sakakibara F; Nakamura J; Hamada Y; Wakao T; Hara T; Mori K; Naruse K; Nakashima E; Sakamoto N
    J Pharmacol Exp Ther; 1996 Jan; 276(1):49-55. PubMed ID: 8558455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of evening primrose oil on nerve function and capillarization in streptozotocin-diabetic rats: modulation by the cyclo-oxygenase inhibitor flurbiprofen.
    Cameron NE; Cotter MA; Dines KC; Robertson S; Cox D
    Br J Pharmacol; 1993 Aug; 109(4):972-9. PubMed ID: 8401950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of nitrosative stress in early neuropathy and vascular dysfunction in streptozotocin-diabetic rats.
    Obrosova IG; Drel VR; Oltman CL; Mashtalir N; Tibrewala J; Groves JT; Yorek MA
    Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1645-55. PubMed ID: 17911342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-oxidant and pro-oxidant effects on nerve conduction velocity, endoneurial blood flow and oxygen tension in non-diabetic and streptozotocin-diabetic rats.
    Cameron NE; Cotter MA; Archibald V; Dines KC; Maxfield EK
    Diabetologia; 1994 May; 37(5):449-59. PubMed ID: 8056181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.